Viridian Therapeutics Statistics

Total Valuation

LON:0K1R has a market cap or net worth of GBP 2.10 billion. The enterprise value is 1.90 billion.

Market Cap	2.10B
Enterprise Value	1.90B

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	95.44M
Shares Outstanding	n/a
Shares Change (YoY)	+34.66%
Shares Change (QoQ)	+0.23%
Owned by Insiders (%)	0.04%
Owned by Institutions (%)	97.56%
Float	90.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	39.94
PB Ratio	5.62
P/TBV Ratio	9.00
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-10.41
EV / Sales	36.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.83

Financial Position

The company has a current ratio of 11.28, with a Debt / Equity ratio of 0.05.

Current Ratio	11.28
Quick Ratio	11.06
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	-0.07
Interest Coverage	-107.06

Financial Efficiency

Return on equity (ROE) is -49.89% and return on invested capital (ROIC) is -32.26%.

Return on Equity (ROE)	-49.89%
Return on Assets (ROA)	-30.08%
Return on Invested Capital (ROIC)	-32.26%
Return on Capital Employed (ROCE)	-61.66%
Weighted Average Cost of Capital (WACC)	9.63%
Revenue Per Employee	368,271
Profits Per Employee	-1.28M
Employee Count	143
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +63.04% in the last 52 weeks. The beta is 0.98, so LON:0K1R's price volatility has been similar to the market average.

Beta (5Y)	0.98
52-Week Price Change	+63.04%
50-Day Moving Average	31.79
200-Day Moving Average	22.02
Relative Strength Index (RSI)	37.33
Average Volume (20 Days)	555

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.04

Income Statement

In the last 12 months, LON:0K1R had revenue of GBP 52.66 million and -182.50 million in losses. Loss per share was -2.25.

Revenue	52.66M
Gross Profit	-184.04M
Operating Income	-241.50M
Pretax Income	-224.65M
Net Income	-182.50M
EBITDA	-241.15M
EBIT	-241.50M
Loss Per Share	-2.25

Full Income Statement

Balance Sheet

The company has 365.20 million in cash and 18.00 million in debt, with a net cash position of 347.20 million.

Cash & Cash Equivalents	365.20M
Total Debt	18.00M
Net Cash	347.20M
Net Cash Per Share	n/a
Equity (Book Value)	374.18M
Book Value Per Share	2.84
Working Capital	387.75M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -242.50 million and capital expenditures -274,514, giving a free cash flow of -242.78 million.

Operating Cash Flow	-242.50M
Capital Expenditures	-274,514
Free Cash Flow	-242.78M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-458.57%
Pretax Margin	-426.58%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0K1R does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-34.66%
Shareholder Yield	-34.66%
Earnings Yield	-8.68%
FCF Yield	-11.54%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 13, 2020. It was a reverse split with a ratio of 0.0666666667.

Last Split Date	Nov 13, 2020
Split Type	Reverse
Split Ratio	0.0666666667

Scores

LON:0K1R has an Altman Z-Score of 7.81 and a Piotroski F-Score of 2.

Altman Z-Score	7.81
Piotroski F-Score	2